• Thu, June 13, 2024
Yasmeen Rahimi Initiated (BNTC) at Buy and Held Target at $30 on, Jun 13th, 2024
Yasmeen Rahimi of Piper Sandler, Initiated "Benitec Biopharma Inc." (BNTC) at Buy and Held Target at $30 on, Jun 13th, 2024.
Yasmeen has made no other calls on BNTC in the last 4 months.
There is 1 other peer that has a rating on BNTC. Out of the 1 peers that are also analyzing BNTC, 0 agree with Yasmeen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Yasmeen
- Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Increased Target to $16 on, Monday, April 22nd, 2024
Like: 👍
